Also trades as: WGSWW (NASDAQ) · $vol 0M
WGS NASDAQ
GeneDx Holdings Corp.
1W: +21.8%
1M: -32.2%
3M: -42.3%
YTD: -64.2%
1Y: -34.4%
3Y: +650.1%
5Y: -87.1%
$47.31
-0.02 (-0.04%)
Weekly Expected Move ±27.4%
$18
$30
$41
$52
$63
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
1 bullish
0 neutral
1 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (90)
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?
Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. (NASDAQ:WGS) on Behalf of GeneDx Stockholders and Encourages Investors with Losses to Contact the Firm
Corvex Management adds CoStar Group, Lionsgate Studios, and exits Oracle among Q1 moves
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
Why Is GeneDx Stock Surging Thursday?
Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud
INVESTOR ALERT: Investigation of GeneDx Holdings Corp. (WGS) announced by Holzer & Holzer, LLC
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
WGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to Potentially Recover Money Through The Firm's Investigation
Crude Oil Down 4%; PayPal Shares Fall After Q1 Results
12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earnings
Why GeneDX Stock Is Plummeting Today
GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Why Sterling Infrastructure Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates
GeneDx (WGS) Q1 2026 Earnings Transcript
GeneDx plummets on lower 2026 guidance, Q1 misses
12 Health Care Stocks Moving In Monday's After-Market Session
GeneDx Holdings Non-GAAP EPS of -$0.28 misses by $0.26, revenue of $102.25M misses by $10.2M
GeneDx (WGS) Q1 2025 Earnings Call Transcript
GeneDx (WGS) Q2 2025 Earnings Transcript
Here are the major earnings after the close Monday
Earnings Scheduled For May 4, 2026
Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?
Three Best Genomics Stocks for Your Portfolio in 2026
Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
CNC Combines Its North Carolina Units to Expand Statewide Footprint
Cathie Wood's weekly moves signal shift to AI, precision medicine
JPMorgan Chase & Co. Has $3 Million Position in GeneDx Holdings Corp. $WGS
New Strong Buy Stocks for April 2nd
New Strong Buy Stocks for April 2nd
Pediatrix Ties Up to Provide Better Maternal Care in Tennessee
Assenagon Asset Management S.A. Has $26.78 Million Stake in GeneDx Holdings Corp. $WGS
Reasons Behind Holding Humana Shares: What Investors Need to Know
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for March 18th
Cathie Wood's weekly recap: adds JOBY, CRSP, TEM, sells TER, TXG, CRCL
100,284 Shares in GeneDx Holdings Corp. $WGS Bought by Capital International Investors
WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Wall Street Analysts Believe GENEDX HOLDINGS (WGS) Could Rally 77.81%: Here's is How to Trade
Intech Investment Management LLC Has $962,000 Holdings in GeneDx Holdings Corp. $WGS
Here's Why Ensign Group Shares Are Attracting Investors Now
ARK Investment Management LLC Purchases New Stake in GeneDx Holdings Corp. $WGS
Amova Asset Management Americas Inc. Invests $31.44 Million in GeneDx Holdings Corp. $WGS
Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a Turnaround
GeneDx Holdings Corp. (NASDAQ:WGS) Given Consensus Rating of “Moderate Buy” by Brokerages
GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell?
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
GeneDx to Participate in Upcoming Investor Conferences
These Analysts Slash Their Forecasts On GeneDx After Q4 Results
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade)
GeneDx rises on Q4 beats, reiterating 2026 revenue guidance
GeneDx outlines $540M–$555M 2026 revenue target as company accelerates market expansion with new sales force
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Beat Estimates
GeneDx Holdings Non-GAAP EPS of $0.18 beats by $0.06, revenue of $121M beats by $0.56M
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
Here are the major earnings before the open Monday
GeneDx Holdings Corp. Q4 2025 Earnings Preview
CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum
Why is GeneDx stock crashing on Monday?
GeneDx Partners With Komodo Health to Advance Rare Disease Research
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
Financial Analysis: GeneDx (NASDAQ:WGS) & Todos Med (OTCMKTS:TOMDF)
Assenagon Asset Management S.A. Has $1.52 Million Stock Position in GeneDx Holdings Corp. $WGS
GeneDx (NASDAQ:WGS) CFO Sells $554,618.85 in Stock
Katherine Stueland Sells 10,857 Shares of GeneDx (NASDAQ:WGS) Stock
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
Cim LLC Purchases New Shares in GeneDx Holdings Corp. $WGS
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of “Moderate Buy” from Analysts
Ardsley Advisory Partners LP Takes $7.39 Million Position in GeneDx Holdings Corp. $WGS
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS